Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine vs Chlorpromazine in Treatment-Refractory Schizophrenia
NCT00169039Phase 4Terminated
- Sponsor
- Harvard Medical School
- Start
- Dec 1994
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clozapine in schizophrenia (2 arms), sponsored by Harvard Medical School. Primary endpoints: Brief Psychiatric Rating Scale at 12 weeks, Clinical Global Impression at 12 weeks and 4 more. Started Dec 1994; status: terminated.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00169039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169039.